Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37


Chimeric autologous/allogeneic constructs for skin regeneration.

Rasmussen CA, Tam J, Steiglitz BM, Bauer RL, Peters NR, Wang Y, Anderson RR, Allen-Hoffmann BL.

Mil Med. 2014 Aug;179(8 Suppl):71-8. doi: 10.7205/MILMED-D-13-00480.


TCDD induces dermal accumulation of keratinocyte-derived matrix metalloproteinase-10 in an organotypic model of human skin.

De Abrew KN, Thomas-Virnig CL, Rasmussen CA, Bolterstein EA, Schlosser SJ, Allen-Hoffmann BL.

Toxicol Appl Pharmacol. 2014 May 1;276(3):171-8. doi: 10.1016/j.taap.2014.02.010. Epub 2014 Feb 24.


Classical human epidermal keratinocyte cell culture.

Rasmussen C, Thomas-Virnig C, Allen-Hoffmann BL.

Methods Mol Biol. 2013;945:161-75. doi: 10.1007/978-1-62703-125-7_11.


Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds.

Gibson AL, Thomas-Virnig CL, Centanni JM, Schlosser SJ, Johnston CE, Van Winkle KF, Szilagyi A, He LK, Shankar R, Allen-Hoffmann BL.

Wound Repair Regen. 2012 May-Jun;20(3):414-24. doi: 10.1111/j.1524-475X.2012.00786.x.


Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial Results.

Schurr MJ, Foster KN, Lokuta MA, Rasmussen CA, Thomas-Virnig CL, Faucher LD, Caruso DM, Allen-Hoffmann BL.

Adv Wound Care (New Rochelle). 2012 Apr;1(2):95-103.


A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.

Thomas-Virnig CL, Allen-Hoffmann BL.

Adv Wound Care (New Rochelle). 2012 Apr;1(2):88-94.


Chimeric Human Skin Substitute Tissue: A Novel Treatment Option for the Delivery of Autologous Keratinocytes.

Rasmussen CA, Allen-Hoffmann BL.

Adv Wound Care (New Rochelle). 2012 Apr;1(2):57-62.


StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

Centanni JM, Straseski JA, Wicks A, Hank JA, Rasmussen CA, Lokuta MA, Schurr MJ, Foster KN, Faucher LD, Caruso DM, Comer AR, Allen-Hoffmann BL.

Ann Surg. 2011 Apr;253(4):672-83. doi: 10.1097/SLA.0b013e318210f3bd.


The StrataTest® human skin model, a consistent in vitro alternative for toxicological testing.

Rasmussen C, Gratz K, Liebel F, Southall M, Garay M, Bhattacharyya S, Simon N, Vander Zanden M, Van Winkle K, Pirnstill J, Pirnstill S, Comer A, Allen-Hoffmann BL.

Toxicol In Vitro. 2010 Oct;24(7):2021-9. doi: 10.1016/j.tiv.2010.07.027. Epub 2010 Aug 3.


Visualization of morphological and molecular features associated with chronic ischemia in bioengineered human skin.

Gill EM, Straseski JA, Rasmussen CA, Liliensiek SJ, Eliceiri KW, Ramanujam N, White JG, Allen-Hoffmann BL.

Microsc Microanal. 2010 Apr;16(2):117-31. doi: 10.1017/S1431927610000103. Epub 2010 Mar 4.


Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.

Rasmussen CA, Gibson AL, Schlosser SJ, Schurr MJ, Allen-Hoffmann BL.

Ann Surg. 2010 Feb;251(2):368-76. doi: 10.1097/SLA.0b013e3181c1ab5f.


Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen.

Straseski JA, Gibson AL, Thomas-Virnig CL, Allen-Hoffmann BL.

Wound Repair Regen. 2009 Jul-Aug;17(4):606-16. doi: 10.1111/j.1524-475X.2009.00515.x.


Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.

Schurr MJ, Foster KN, Centanni JM, Comer AR, Wicks A, Gibson AL, Thomas-Virnig CL, Schlosser SJ, Faucher LD, Lokuta MA, Allen-Hoffmann BL.

J Trauma. 2009 Mar;66(3):866-73; discussion 873-4. doi: 10.1097/TA.0b013e31819849d6.


Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.

Thomas-Virnig CL, Centanni JM, Johnston CE, He LK, Schlosser SJ, Van Winkle KF, Chen R, Gibson AL, Szilagyi A, Li L, Shankar R, Allen-Hoffmann BL.

Mol Ther. 2009 Mar;17(3):562-9. doi: 10.1038/mt.2008.289. Epub 2009 Feb 3.


Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes.

Gibson AL, Schurr MJ, Schlosser SJ, Comer AR, Allen-Hoffmann BL.

Tissue Eng Part A. 2008 May;14(5):629-38. doi: 10.1089/tea.2007.0126.


Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte cultures.

Slavik MA, Allen-Hoffmann BL, Liu BY, Alexander CM.

BMC Dev Biol. 2007 Feb 17;7:9.


Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors.

Ji L, Allen-Hoffmann BL, de Pablo JJ, Palecek SP.

Tissue Eng. 2006 Apr;12(4):665-79.


In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin.

Loertscher JA, Lin TM, Peterson RE, Allen-Hoffmann BL.

Toxicol Sci. 2002 Aug;68(2):465-72.


2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture.

Loertscher JA, Sattler CA, Allen-Hoffmann BL.

Toxicol Appl Pharmacol. 2001 Sep 1;175(2):121-9.


Treatment of normal human keratinocytes with 2,3,7,8-tetrachlorodibenzo-p-dioxin causes a reduction in cell number, but no increase in apoptosis.

Loertscher JA, Sadek CS, Allen-Hoffmann BL.

Toxicol Appl Pharmacol. 2001 Sep 1;175(2):114-20.


Supplemental Content

Loading ...
Support Center